Media

Check out all our news

5 September 2025
11 August 2025
14 July 2025
30 June 2025
3 June 2025
15 May 2025
8 April 2025
13 March 2025
18 February 2025
30 January 2025
10 December 2024
9 December 2024
28 November 2024
24 October 2024
19 September 2024
2 September 2024
9 August 2024
18 July 2024
28 June 2024
7 June 2024
10 May 2024
16 April 2024
2 April 2024
13 February 2024
11 January 2024
22 December 2023
20 July 2023
30 June 2023
12 May 2023
24 February 2023
13 February 2023
21 December 2022
14 September 2022
19 July 2022
30 June 2022
15 June 2022
8 June 2022
1 June 2022
1 June 2022
11 May 2022
10 May 2022
06 April 2022
01 April 2022
20 March 2022
17 March 2022
15 March 2022
01 March 2022
16 December 2021
29 October 2021
01 July 2021
30 March 2021
26 January 2021

Stay up to date
with all our news,
including press releases,
by subscribing to
our newsletter below

Press Releases

See all
press releases
issued by bonyf

In the Press

See all
articles published
about bonyf

Latest News

Stay up to date with
all our latest corporate
and product news

Press Releases

Periocream: The Future Commercial Winner for bonyf

Periocream: The Future Commercial Winner for bonyf

Knokke-Heist (Belgium), 11 August 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) is preparing to launch Periocream, a groundbreaking dental treatment designed exclusively for dental professionals. At bonyf, we expect our Notified Body to release the final report shortly, confirming the product’s readiness for market.

Read More
Annual Results 2024

Annual Results 2024

Knokke-Heist (Belgium), 30 June 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) presents its 2024 financial statements, approved by its Board of Directors and audited by its Statutory Auditors.

Read More
bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth Strategy

bonyf NV Announces First Exports to the United States with Honest Pharma, Marking a Key Milestone in USA Growth Strategy

Knokke-Heist (Belgium), 15 May 2025, 6:00 p.m.; bonyf NV (Ticker: MLBON) is pleased to announce the successful launch of its first exports to the United States through a new partnership with Honest Pharma, a U.S.-based healthcare company backed by Investment 360, an investor group with a strong track record of success across a range of global industries.

Read More
bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne

bonyf recently secures its EU Patent, US patent pending, for PerioTabs® & PerioCream, launch in March 2025 at the IDS Cologne

Knokke-Heist (Belgium), 13 March 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) presents PerioTabs® and Periocream at the future exhibition in Cologne from 25-29 March 2025 at the IDS, leading global trade fair for the dental community. PerioTabs®-Periocream’s participation in this premier event highlights its potential to revolutionize dental care practices globally. Visit bonyf at the IDS Hall 5.2, Booth 131.

Read More
bonyf Announces Plans for Dual Listing on Nasdaq and Euronext Paris with a Five-Step Strategy

bonyf Announces Plans for Dual Listing on Nasdaq and Euronext Paris with a Five-Step Strategy

Knokke-Heist (Belgium), 18 February 2025, 6:00 a.m.; bonyf NV (Ticker: MLBON) today announced its strategic plan to pursue a dual listing on the Nasdaq Stock Market while maintaining its current listing on Euronext Paris. This initiative is aimed at expanding the company’s global footprint, diversifying its investor base, and accelerating growth opportunities in the U.S. and international markets.

Read More
bonyf R&D presents its two latest innovations at IDS 2025 in Cologne

bonyf R&D presents its two latest innovations at IDS 2025 in Cologne

Knokke-Heist (Belgium), 30 January 2025, 6:00 p.m.; bonyf NV (Ticker: MLBON) presents its 2 latest innovations at the dental future exhibition in Cologne from 25-29 March 2025 at the IDS, leading global trade fair for the dental community in Cologne. Visit bonyf at the IDS Hall 5.2, Booth 131.

Read More
bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market

bonyf and Honest Pharma are pleased to announce a Strategic Alliance to bring revolutionary oral care products to the US market

Knokke-Heist (Belgium), 10 December 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is committed to advancing oral health solutions that enhance patient well-being. Today, the company is pleased to announce a significant milestone: the successful certification of NitrAdine® Disinfecting Tablets under the stringent European Union’s Medical Device Regulation (MDR), marking a new chapter in its pursuit of excellence.

Read More
bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions

bonyf Achieves MDR Certification, Strengthening Commitment to Excellence in Oral Care Solutions

Knokke-Heist (Belgium), 9 December 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is committed to advancing oral health solutions that enhance patient well-being. Today, the company is pleased to announce a significant milestone: the successful certification of NitrAdine® Disinfecting Tablets under the stringent European Union’s Medical Device Regulation (MDR), marking a new chapter in its pursuit of excellence.

Read More
bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India

bonyf expands its global formulation footprint through a strategic alliance with Group Pharmaceuticals Ltd, signing a license agreement to produce NitrAdine® for India

Knokke-Heist (Belgium), 28 November 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) and Group pharmaceuticals Ltd are pleased to announce a strategic alliance with a license agreement on the NitrAdine® formulation to manufacture and distribute in India the bonyf products NitrAdine® denture cleansing & disinfecting tablets.

Read More
Annual Results 2023

Annual Results 2023

Ghent (Belgium), 19 September 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) presents its 2023 financial statements, approved by its Board of Directors and audited by its Statutory Auditors.

Read More
bonyf exhibits at PLMA Amsterdam on 28-29 May 2024

bonyf exhibits at PLMA Amsterdam on 28-29 May 2024

Ghent (Belgium), 16 April 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) is thrilled to announce that our company is expanding its clientele in 2024, largely attributed to our successful participation in last year's PLMA exhibition in Amsterdam.

Read More
New Key Partnerships

New Key Partnerships

Ghent (Belgium), 11 January 2024, 6:00 a.m.; bonyf NV (Ticker: MLBON) has secured key partnerships with an Austria-German multinational and a leading pharma company in Ukraine.

Read More
Trading Resume under Euronext

Trading Resume under Euronext

Ghent (Belgium), 22 December 2023, 6:00 a.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, had asked for its shares to be suspended from trading following interest from a strategic investor in acquiring a 30% stake.

Read More
bonyf’s 2022 financial statements made available

bonyf’s 2022 financial statements made available

Ghent (Belgium), 20 July 2023, 6:00 p.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, presents its 2022 consolidated financial statements, approved by its Board of Directors and audited by its Statutory Auditors

Read More
Delay in release of financial statements 2022

Delay in release of financial statements 2022

Ghent (Belgium), 30 June 2023; bonyf NV (Mnemonic: MLBON), a leading manufacturer of oral and denture care products announces its delay in the preparation and audit of the financial statements for the 2022 financial year.

Read More
Trading Suspension

Trading Suspension

Ghent (Belgium), 24 February 2023, 6:00 p.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, announces the suspension of the listing of its shares at the request of the company.

Read More
25% increase in turnover in H1 2022

25% increase in turnover in H1 2022

Ghent (Belgium), 14 September, 2022, 6 p.m.; bonyf NV (Mnemonic: MLBON), the next-generation oral comfort expert, announces a strong growth in turnover for the first half of 2022 ...

Read More
Annual results 2021

Annual results 2021

Ghent (Belgium), 30 June, 2022, 7 p.m.; bonyf NV (ticker symbol: MLBON), the next-generation oral comfort expert, presents its 2021 financial statements, approved by ...

Read More
bonyf raises awareness on World Oral Health Day

bonyf raises awareness on World Oral Health Day

Ghent (Belgium), 20 March 2022, 08.00am; bonyf NV (ticker: MLBON), experts in next generation oral and dental care, joins World Oral Health Day on 20 March 2022 in emphasising the importance of oral care, your mouth being a vital organ for the prevention of many diseases.

Read More
bonyf announces listing on Paris Euronext

bonyf announces listing on Paris Euronext

Ghent (Belgium), 15 March 2022, 10:15am; bonyf NV (Ticker symbol: MLBON), the experts in next-generation oral and dental care, announces it will go public on Euronext Access® by direct listing on 17 March 2022.

Read More

In the Press

Latest News

bonyf exhibits at the largest private label trade show

bonyf exhibits at the largest private label trade show

VADUZ, Liechtenstein, 12 May 2023 – bonyf, a leading manufacturer of oral and denture care products is excited to announce its participation in the Private Label Manufacturers Association's (PLMA) annual trade show in Amsterdam.

Read More
bonyf is granted TFDA approval in Taiwan

bonyf is granted TFDA approval in Taiwan

VADUZ, Liechtenstein, 13 February 2023 – To comply with new stringent regulations enforced in Taiwan for the sale of medical device products, bonyf has received the TFDA (Taiwan Food and Drug Administration) approval for 2 core products.

Read More
Inaugural shareholder newsletter released

Inaugural shareholder newsletter released

GHENT, Belgium, 21 December 2022 – bonyf NV releases to its new shareholders the inaugural shareholder newsletter. The shareholder newsletter has been released by bonyf’s CEO and Founder, Mr Jean-Pierre Bogaert.

Read More